Cargando…

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging

INTRODUCTION: Current monoanalyte biomarkers are ineffective in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). NETest, a novel multianalyte signature, provides molecular information relevant to disease biology. AIM(S): Independently validate NETest to diagnose GEP-NETs and identify progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malczewska, Anna, Witkowska, Magdalena, Makulik, Karolina, Bocian, Agnes, Walter, Agata, Pilch-Kowalczyk, Joanna, Zajęcki, Wojciech, Bodei, Lisa, Oberg, Kjell, Kos-Kudła, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479193/ https://www.ncbi.nlm.nih.gov/pubmed/30865931 http://dx.doi.org/10.1530/EC-19-0030

Ejemplares similares

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019)

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
por: Malczewska, Anna, et al.
Publicado: (2020)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
por: Malczewska, A., et al.
Publicado: (2020)

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Role of Leptin and Adiponectin in Carcinogenesis
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
por: Rosiek, Violetta, et al.
Publicado: (2023)

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
por: Rosiek, Violetta, et al.
Publicado: (2023)

Treatment of neuroendocrine tumors: new recommendations based on the CLARINET study
por: Kos-Kudła, Beata
Publicado: (2015)

Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
por: Roll, Wolfgang, et al.
Publicado: (2021)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
por: Dromain, Clarisse, et al.
Publicado: (2021)

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
por: Rosiek, Violetta, et al.
Publicado: (2023)

Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors
por: Öberg, Kjell
Publicado: (2012)

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors – results of interim analysis
por: Orlewska, Ewa, et al.
Publicado: (2014)

Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
por: Gossing, Wilhelm, et al.
Publicado: (2020)

Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
por: Kidd, Mark, et al.
Publicado: (2019)

Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
por: Öberg, Kjell
Publicado: (2012)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
por: Kos-Kudła, Beata, et al.
Publicado: (2017)

Selected Parameters of Bone Turnover in Neuroendocrine Tumors—A Potential Clinical Use?
por: Strzelczyk, Janusz, et al.
Publicado: (2023)

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017)

Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms
por: Strzelczyk, Janusz, et al.
Publicado: (2022)

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
por: Skubisz, Karolina, et al.
Publicado: (2023)

The Potential Role of Liquid Biopsies in Advancing the Understanding of Neuroendocrine Neoplasms
por: Shah, Dinakshi, et al.
Publicado: (2021)

Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [(177)Lu]Lu-DOTA-TATE or [(177)Lu]Lu-DOTA-TATE and [(90)Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
por: Durma, Adam Daniel, et al.
Publicado: (2023)

Assessment of Osteoporosis and Vitamin D3 Deficiency in Patients with Idiopathic Benign Paroxysmal Positional Vertigo (BPPV)
por: Miśkiewicz-Orczyk, Katarzyna, et al.
Publicado: (2023)

Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
por: Starzyńska, Teresa, et al.
Publicado: (2020)

Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support
por: Szkukalek, Judita, et al.
Publicado: (2021)

Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells Using Membrane-Based SERS Platform: A New Diagnostic Approach for ‘Liquid Biopsy’
por: Kamińska, Agnieszka, et al.
Publicado: (2019)

Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience
por: Kunikowska, Jolanta, et al.
Publicado: (2020)

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022)

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
por: Li, Su-Chen, et al.
Publicado: (2015)

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
por: Knappskog, Stian, et al.
Publicado: (2023)

Gastric neuroendocrine cells and secretory products.
por: Oberg, K.
Publicado: (1998)

Biochemical diagnosis of neuroendocrine GEP tumor.
por: Oberg, K.
Publicado: (1997)

Complications following endoscopic treatment of vesicoureteric reflux with Deflux(®) – two case studies
por: Życzkowski, Marcin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s1l550l4djjto4u0f6me5nsudj